A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia Patients

Clinical trial NCT02317861 · COMPLETED

Trial details

NCT number: NCT02317861
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gout and Asymptomatic Hyperuricemia

Start date: 2014-12-01
Primary completion: 2015-06-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.